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ABSTRACT
Angiomyolipomas (AMLs) are mesenchymal neoplasms, named so because 
of the complex tissue composition represented by variable proportions of 
mature adipose tissue, smooth muscle cells, and dysmorphic blood vessels. 
Although AMLs may rise in different sites of the body, they are mostly observed 
in the kidney and liver. In the case of renal AMLs, they are described in two 
types: isolated AMLs and AMLs associated with tuberous sclerosis (TS). While 
most cases of AMLs are found incidentally during imaging examinations and 
are asymptomatic, others may reach huge proportions causing symptoms. 
Pulmonary lymphangioleiomyomatosis (LAM) is a rare benign disease 
characterized by cystic changes in the pulmonary parenchyma and smooth 
muscle proliferation, leading to a mixed picture of interstitial and obstructive 
disease. AML and LAM constitute major features of tuberous sclerosis 
complex (TSC), a multisystem autosomal dominant tumor-suppressor gene 
complex diagnosis. The authors report the case of a young female patient 
who presented a huge abdominal tumor, which at computed tomography (CT) 
show a fat predominance. The tumor displaced the right kidney and remaining 
abdominal viscera to the left. Chest CT also disclosed pulmonary lesions 
compatible with lymphangioleiomyomatosis. Because of sudden abdominal 
pain accompanied by a fall in the hemoglobin level, the patient underwent an 
urgent laparotomy. The excised tumor was shown to be a giant renal AML with 
signs of bleeding in its interior. The authors call attention to the diagnosis of 
AML and the huge proportions that the tumor can reach, as well as for ruling 
out the TSC diagnosis, once it may impose genetic counseling implications..
Keywords: Angiomyolipoma; Kidney Diseases; Lymphangioleiomyomatosis; Hemorrhage; 
Nephrectomy; Tuberous Sclerosis.
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carcinoma antigen 15-3 (CA 15-3) 5.5 U/mL (RV: 
until 38.5 U/mL); carbohydrate antigen 19-9 (CA 19-
9) 3.6 (RV: until 37 U/mL).
The abdominal plain x-ray showed a 
homogeneous opacification occupying almost the 
entire right hemi abdomen displacing the bowel 
loops to the left (Figure 1).
The abdominal sonographic examination 
showed a poorly defined mass blurring the intra- 
CASE REPORT
A 26-year-old Caucasian female patient 
sought medical care, complaining of a 2-month right 
flank pain. Initially, this symptom had a 30-minute 
duration and was usually triggered by physical 
exertion or by trunk flexion. The pain improved with 
rest. Gradually, the pain became more frequent 
and more intense, accompanied by stiffness of the 
abdominal wall and increased abdominal volume 
reaching proportions that resembled the abdomen 
of an advanced pregnancy. She reported weight 
loss of 3 kg in this period, postprandial bloating, and 
progressive exertional dyspnea. Fever was absent. 
Her past medical history included two pregnancies, 
one cesarean section 6 years before, and one 
vaginal delivery, 4 years ago. She was a smoker 
and her alcoholic beverage consumption was mild. 
On physical examination the patient was in good 
general condition, weight was 57 kg, height was 
1.59 m (BMI = 22.5), blood pressure was 120/80 
mmHg; pulse rate was 72 beats per minute, and 
she was afebrile. Examination of the skin, nails, and 
gums was normal. Upon inspection, the abdomen 
was asymmetric, right bulged where a hardened 
mass was palpable and painful, displacing the liver 
forward and to the left. The remainder of the physical 
examination was normal.
Initial laboratory tests are shown in Table 1. 
Urinalysis was normal. Serum determination of 
carcinoembrionic antigen (CEA) was < 0.5 ng/
mL (reference value [RV] until 2.5 ng/mL), cancer 
antigen–125 (CA-125) 17 U/mL (RV: until 35 U/mL); 
Table 1 – Initial laboratory workup
Exam Result RV Exam Result RV
Hemoglobin 14.0 12.3-15.3 g/dL Glucose 83 70-99 mg/dL
Hematocrit 42.1 36.0-45.0% Creatinine 0.72 0.4-1.3 mg/dL 
Leukocytes 6.19 4.4-11.3 × 10³/mm3 Urea 25 10-50 mg/dL 
Segmented 61 46-75% Sodium 138 136-146 mEq/L
Eosinophil 4 1-4% Potassium 4.7 3.5-5.0 mEq/L
Basophil 2 0-2.5% CRP < 5 mg/L < 5.0 mg/L
Lymphocyte 27 18-40% INR 1.10 1.0
Monocyte 6 2-9% TP 6.7 6.0-8.0 g/dL
Platelet 339 150-400 × 10³/mm3 Albumin 4.2 3.0-5.0 g/dL
CRP = C-reactive protein; INR = international normalized ratio; RV = reference value; TP = total protein.
Figure 1 – Abdominal plain radiography showing 
the displacement of the bowel loops to the left and a 
homogeneous opacity filling the right hemiabdomen.
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relationship with the inferior pole of the right kidney. 
The right adrenal gland, pancreas, and intestinal 
bowels were shifted to the left. The heterogeneous 
mass was richly vascularized, presenting calibrous 
vessels adjacent to its inferior portion and exhibited 
a density predominantly of adipose tissue (Figures 2 
and 3).
Evident lymph adenomegaly was not 
identified. The remaining organs in the abdomen 
were normal. Thoracic CT showed the presence 
of multiple cystic images throughout the lungs 
including the involvement of apices and costophrenic 
recesses (Figure 4) compatible with the diagnosis 
of lymphangioleiomyomatosis, without causing any 
change in the pulmonary function test. Brain CT and 
Doppler echocardiography were normal.
With these clinical, laboratory and imaging 
features, the hypothesis of angiomyolipoma (AML) 
was raised and surgery was indicated, due to the 
tumor size. While waiting for surgery, the patient 
presented an acute worsening of pain, hypotension, 
and pallor. At this time, a fall of 5.3 g/dL in 
hemoglobin determination and 16.9% in hematocrit 
was observed.
Urgent laparotomy was undertaken and the 
surgical findings corresponded to a large tumoral 
mass originating from the anterior surface of the 
right kidney weighing 2,700 g enclosed into the 
retroperitoneum (Figure 5). The right renal and 
adrenal arteries and veins held the tumor blood 
supply. The right kidney and right adrenal were 
excised in conjunction with the tumoral mass. 
Postoperative recovery was uneventful, and the 
patient was discharged after 9 days.
Microscopic examination showed a tumor 
composed of three tissue components: mature 
and retroperitoneal adipose tissue, preventing 
the identification of the pancreas and adjacent 
structures. This mass predominantly occupied 
the epigastric and mesogastric areas, shifting the 
intestinal bowels to the left and the right kidney 
anteriorly and to the left.
The abdominal computed tomography (CT) 
disclosed a huge retroperitoneal mass measuring 
18.0 × 17.0 × 8.7 cm, occupying almost the entire 
right side of the abdomen, exhibiting an intimate 
Figure 2 – Abdominal computed tomography 
(CT) – portal phase – coronal reformatted image 
showing a huge mass occupying half of the abdominal 
volume, crossing the midline, predominantly 
composed of adipose tissue interspersed with 
multiple vascular structures. The right kidney is 
displaced medially. Note the relationship of the 
mass with the renal parenchyma at its lower pole.
Figure 3 – Abdominal axial CT. A – (Image without intravenous contrast injection.) A huge mass occupying the 
right half of the abdomen, crossing the midline, and consisting predominantly of adipose tissue is observed; 
B – Arterial phase; C – Portal phase. Note that the tumoral mass is interspersed with multiple vascular 
structures and the relationship of mass to the renal parenchyma at its lower pole.
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Figure 4 – Thoracic CT, lung window. A – Coronal; B – Right sagittal; C – Left sagittal. A, B, and C show 
several thin-walled pulmonary cysts that are relatively homogeneous in form and dimensions, diffusely 
distributed throughout the lung fields, including the apices and costophrenic sulci, compatible with 
lymphangioleiomyomatosis.
Figure 5 – Gross examination of the tumoral mass represented by a large yellowish and hemorrhagic mass 
measuring 24 cm in its longest axis; A – Right kidney depicted in the centrum of the tumor mass, losing 
definition of its contour at the inferior pole; B – Tumor covered by peritoneum; C- Note the abundance of the 
adipose tissue of the tumoral mass.
Figure 6 – Photomicrography of the tumoral mass. A and B - Renal angiomyolipoma (AML) composed of 
adipose tissue, smooth muscle, and vessels (HE 10 × 20).
adipose tissue, convoluted thick-walled blood 
vessels with frequent hyalinization of the media, 
and interlacing bundles of smooth muscle often 
with perivascular arrangement (Figure 6). The 
immunohistochemical panel was positive for muscle 
actin and markers associated with melanoma 
antigen HMB-45 and Melan-A in the muscular 
component of the neoplasm (Figure 7).
GENETICS ANALYSIS
The patient reported here had no definite 
clinical diagnosis of TSC, suggesting isolated AML 
and LAM. Somatic mutations in either TSC1 or 
TSC2 genes have been reported in isolated AMLs 
and LAM.1,2 Most mutations in isolated renal AMLs 
have been reported in the TSC2 gene, mapped 
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Figure 7 – Photomicrography of the tumoral mass. Renal AML showing positive immunoreactivity. A – Smooth 
muscle actin (AML); B – HMB-45; C – Melan A.
Figure 8 – A - Part of the short arm of human chromosome 16 is depicted, showing the localization of TSC2 
gene, which partially overlaps with PKD1 gene. Molecular, polymorphic markers informative in this study 
are presented, as well as the estimated distance (kilobases, Kb) between consecutive ones; B - Silver-
stained polyacrylamide gels, in which PCR amplification products (8 µL) have been electrophoresed, 
show the migration of DNA bands. Approximate molecular sizes are 91, 130, 189, 121, 124, 118 and 133 
basepairs (bp), respectively for D16S283, STR7, D16S291, KG8, D16S3395, STR3 and D16S521. Two 
bands observed within the expected size are indicated by arrowheads for every locus, each corresponding 
to the amplification of a distinct allele. Slower-moving bands may correspond to heteroduplexes formed by 
hybridization between strands from different allele amplifications or unspecific products. Arrows indicate a 
very faint band in the tumor sample as compared to the leukocyte DNA amplification in both D16S291 and 
KG8 loci. Two results are presented for the KG8 locus, each one from a different sample preparation of DNA 
from the AML-containing paraffin block.
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Figure 9 – Photomicrography of the tumoral mass. Renal AML shows positive immunoreactivity for hamartin 
(TSC1) in (A) and light staining for tuberin (TSC2) in (B) when compared to the negative control (C, anti-
rabbit antibody). 200 X magnification.
Figure 10 – Photomicrography of the kidney. Kidney sections have been submitted to immunohistochemistry 
under the same conditions as in Figure 9. Renal tissue shows relatively similarly strong immunoreactivity for 
hamartin (TSC1, A) and tuberin (TSC2, B), when compared to the negative control (C, anti-rabbit antibody). 
200 X magnification.
to 16p13.3.3 Therefore, we searched for loss of 
heterozygosity at 16p13.3, comparing patient DNA 
from leukocytes and AML tissue. We analyzed 11 
microsatellites, with primers available at http://
www.ncbi.nih.gov/unists. After paraffin removal 
from tissue sample, DNA was purified (QIAGEN, 
Germantown, MD), and polymerase chain reaction 
(PCR) was performed, disclosing seven informative 
microsatellites (heterozygous in patient blood 
sample). Loss of heterozygosity was detected at 
KG8 microsatellite marker, for which the leukocyte 
DNA revealed heterozygosity, and the tumor sample 
had convincing amplification of a single allele, 
whereas for the other one very low intensity PCR 
amplification was observed (Figure 8, arrow). PCR 
testing of a DNA sample prepared from novel AML 
paraffin sections disclosed KG8 heterozygosity even 
for the tumor sample. One possible explanation 
is the presence of more endothelial and fibroblast 
cells in the latter sample, which are part of the tumor 
but should not have the mutation. Nevertheless, we 
also observed loss of heterozygosity at the D16S291 
marker, for which the lower allele band was missing 
when compared to the leukocyte amplification 
product (Figure 8, arrow).
Further immunohistochemistry analyses 
have been carried out to address the expression 
of the TSC proteins, hamartin (TSC1) and tuberin 
(TSC2), with the following antibodies: rabbit 
polyclonal anti-hamartin (HF6, a kind gift of Vijaya 
Ramesh, Massachusetts General Hospital, Boston, 
MA)4 and rabbit polyclonal anti-tuberin (TSC2, IA22, 
Sigma, St Louis, MI). We detected reasonable 
levels of hamartin (TSC1) and relatively low levels 
of tuberin (TSC2) in the AML, when compared to 
the negative control where the primary antibody has 
been omitted (Figure 9). On the other hand, staining 
under the same conditions was observed similarly 
for both hamartin and tuberin in the normal kidney 
tissue (Figure 10), supporting the observation of 
relatively low expression of the TSC2 gene in the 
AML.
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the term ‘‘epithelioid’’ as it applies to AMLs should 
be restricted to a morphologic description of cells 
with an epithelioid pattern as opposed to a spindle 
cell pattern, regardless of whether or not there is 
cytological atypia. Therefore, Brimo et al.16 denote 
AMLs with epithelioid morphology as ‘‘epithelioid 
AMLs’’ that are then divided into epithelioid AMLs with 
and without atypia—the former category associated, 
in the literature, with malignant potential.16
Although angiomyolipoma may rise in 
different sites of the body; namely, hard palate, 
adrenal gland, mediastinum, pancreas, and 
pelvis, they are mostly observed in the kidney 
and liver.17-22 Renal AML has an incidence varying 
between 0.02% and 0.3% (in patients without 
tuberous sclerosis complex [TSC]). They are 
described in two types: isolated angiomyolipoma 
and angiomyolipoma associated with TSC.6,7,15,23 
The former represents almost 80% of cases, which 
typically develop in middle-aged women, and the 
latter represents the remaining 20% associated 
to TSC, known as Bourneville disease.6,24 Despite 
the fact that there is no significant difference in the 
frequency of AML detected in asymptomatic males 
or females, in patients treated surgically for AML, 
females outnumber males by a ratio of 4.8:1 in 
those with TSC, and 4.5:1 in those without TSC.25,26 
The consistent increased frequency in females may 
be due, in part, to hormonal differences as AMLs 
express progesterone and estrogen receptors, 
and perhaps explains the rapid growth and higher 
propensity to hemorrhage during pregnancy.6,27
While most cases of AML are found 
incidentally during imaging examinations and are 
asymptomatic, others may reach huge proportions 
presenting life-threatening symptoms or encroaching 
insidiously on the normal renal parenchyma leading 
to renal failure.28,29 When symptomatic (40% of the 
cases), AML can present as a palpable mass, flank 
pain, or hematuria. Usually tumors do not uniformly 
become symptomatic until they reach the size of 
4 cm; after that, symptoms will be present in 68-
80% of patients.30 Ruptures and renal hemorrhage 
have been reported to occur with lesions > 4 cm.7,15 
Dysmorphic blood vessels within AML may appear 
thick, but they lack normal elastin; they are tortuous 
and do not show normal tapering.6 Aneurysms 
frequently develop as the AML enlarges, which 
can rupture causing retroperitoneal hemorrhage 
accompanied by sudden flank or back pain and 
signs of shock—the dreadful morbidity associated 
with AML, called Wunderlich syndrome.31 This 
complication occurs in 50–60% of the cases,6 and 
in up to 20% imposes nephrectomy.23
DISCUSSION
Renal AMLs are benign mesenchymal 
neoplasm, named so by Morgan et al.5 because 
of the complex tissue composition represented 
by a variable proportion of mature adipose tissue, 
smooth muscle cells, and dysmorphic blood 
vessels. However, Grawitz, in 1900, had already 
used this denomination to describe a large 
renal tumor comprised of fat, muscle, and blood 
vessels.6-8 AMLs are derived from a unique cell that 
has been designated as perivascular epithelioid 
cell. The classical perivascular epithelioid cell 
is typically clustered around blood vessels and 
may be scattered haphazardly within an AML.9,10 
These cells show positive immunoreactivity for 
HMB-45 and other melanocytic markers. Other 
studies showed that tumor cells of pulmonary 
lymphangiomyomatosis also express HMB-45, as 
well as sugar tumor of the lung, creating the concept 
of a family of tumors called PEComas.11 The World 
Health Organization recognized the PEComa family 
as a group of mesenchymal tumors composed of 
these distinctive perivascular epithelioid cells.12
By definition, AML is considered to be benign 
even in the event of vascular or regional lymph 
node involvement, which is regarded as indicative 
of multifocal growth rather than an aggressive 
behavior.13,14 They may involve surrounding tissues 
like perinephric fat, renal sinus, renal vein, lymph 
nodes, and adrenal glands; invade the inferior vena 
cava and the right atrium, posing a frequent challenge 
to be differentiated from renal cell carcinoma.6,15 
Classical AMLs present abundant fat tissue and 
therefore are somewhat easily diagnosed by CT or 
magnetic resonance imaging (MRI). However, many 
of them are not suspected because of the lack of fat 
tissue evidence, being called poor-fat AMLs, which 
do not differ in prognosis from the classical ones.
AMLs may also be classified as monophasic 
when they are composed predominantly or 
exclusively of one component, or triphasic when 
the three components (smooth muscle, fat and 
dysmorphic blood vessels) are present. The AMLs 
were recently classified as regular or clinically 
benign AMLs (when no epithelioid component is 
present) and epithelioid angiomyolipoma (EAML) 
(formerly called atypical AML), which are composed 
partially or entirely of atypical large epithelioid cells 
with abundant cytoplasm, vesicular nuclei, and 
prominent nucleoli.16 This denomination requires 
the presence of a minimum of 5% of the epithelioid 
component.15 Approximately one-third of the EAML 
have been reported to present metastasis or local 
recurrences.16,17 Epithelioid cellular morphology also 
can be seen in regular benign AMLs. Consequently, 
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and epithelioid smooth muscle cells of AML are 
positive for vimentin, muscle-specific actin, smooth 
muscle actin, desmin, and CD 117 (c-KIT).10,39 The 
development of human melanoma black-45 (HMB-
45) and other melanocytic markers such as Melan 
A, has increased the reliability of the biopsies, as 
virtually all AMLs stain positive for these antibodies. 
Epithelial markers such as cytokeratin, frequently 
seen in RCC, are absent in AML, and HBM-45 is 
negative in RCC.40
Treatment of AML depends on the tumor 
size, the presence of symptoms, and, more recently, 
on the size of aneurysms detected by angiography. 
Symptomatic patients with lesions ≥ 4 cm or 
aneurysm > 5 mm should be treated with selective 
transcatheter renal artery embolization, enucleation, 
or partial nephrectomy. Patients asymptomatic 
should be monitored every 6 months.41,42 The 
2012 International Tuberous Sclerosis Complex 
Consensus Conference recently reviewed the 
guidelines for management of TSC patients, and 
recommend that asymptomatic, growing AMLs 
larger than 3 cm should have mTOR inhibitors as 
first–line therapy.43 The optimal treatment of AML 
is logically focused on sparing renal tissue23, but in 
case of huge tumors and hemorrhage accompanied 
by hemodynamic instability or shock, nephrectomy 
is unavoidable.
We observed loss of heterozygosity in two 
loci linked to TSC2 gene, KG8 and D16S291. 
Although a second sample was not able to confirm 
KG8 results, we should take into consideration that 
the tumor has not been microdissected and it is 
composed of different cell types involved in blood 
vessel and interstitium formation that should lack the 
mutation. KG8 and D16S291 are adjacent markers 
in our study. PKD1 gene lies between them, in a 
200-Kb DNA segment. No intragenic microsatellite 
is available for the TSC2 gene. KG8 lies in its very 
3’-end (see Figure 8). Therefore, the two losses of 
heterozygosity observed in this study are indicative 
of a single mutational event in the tissue that 
originated the tumor, probably a deletion of one copy 
of TSC2. The extension of this TSC2 somatic gene 
deletion could not be ascertained, though it should 
include its 3’-end and extends downstream for at 
least 200 Kb. Moreover, our results suggest that 
the other somatic mutational hit, which is necessary 
to the oncogenic cascade, is unlikely to be a large 
deletion within the region where the microsatellites 
are located. It could be either, an intragenic 
deletion, a point mutation or an inactivating post-
translational modification of the TSC2 protein.44 Due 
to the paucity of polymorphic microsatellite markers 
within the TSC2 gene and the low quality of DNA 
obtained from the paraffin-embedded sample, we 
Pulmonary lymphangioleiomyomatosis 
(LAM) is a rare benign disease characterized by 
cystic changes in the pulmonary parenchyma 
and smooth muscle proliferation, leading to 
a mixed picture of interstitial and obstructive 
disease. Complications of this entity may comprise 
pneumothorax, chylothorax, and hemoptysis. 
Similarly to AML, LAM exhibits estrogen receptors 
reacting to hormonal influence. Anti-estrogen drugs 
(like tamoxifen) have proved to be beneficial in 
slowing the disease process.7
AML and LAM constitute major features of 
TSC diagnosis. The association between AML and 
TSC accounts for 20%. In these cases, AMLs are 
typically large lesions and bilateral; on the other 
hand, 80% of patients with TSC present AML.
LAM is also a major feature for clinical 
diagnosis of TSC and can be detected in 26-39% 
of these patients. The concomitance of LAM and 
AML in patients with TSC diagnosis is 60%.15,32,33 
Regarding the revised criteria for the clinical 
diagnosis of TSC,34 the presence of two major 
features are sufficient for definite clinical diagnosis, 
but when AML and LAM are simultaneously present, 
another feature of TSC is required for a definite 
diagnosis.35 In the case reported here, the patient 
did not present skin or nail abnormalities; the brain 
CT and Doppler echocardiogram were normal. 
Fundoscopic examination was normal. Based on as 
much clinical and laboratory data as we were able 
to get, the diagnosis of TSC could not be achieved.
Imaging diagnosis of AML include ultrasound, 
color flow Doppler, CT, MRI. The classical ultrasound 
appearance of an AML is the hyper-reflective 
lesion with acoustic shadowing. AML has been 
described as the most hyper-reflective renal lesion, 
due to a combination of its fat content, the blood 
vessels within the tumor, and its heterogeneous 
nature.36,37 The subset of an AML with a minimal 
fat component, which represents a minority, will 
present as isoreflective to renal parenchyma. The 
demonstration of fat on CT is highly suggestive of 
AML, although not pathognomonic, but remains the 
major discriminative sign between AML and renal 
cell carcinoma (RCC). In an acute setting, CT is 
the most useful imaging examination, assessing 
hemorrhage and establishing an underlying 
diagnosis.38 Diagnosis of AML by MRI also depends 
on the detection of fat within the lesion, which is 
assessed by the difference between fat-suppressed 
and non-fat-suppressed sequences.30
In case of equivocal imaging results, a 
biopsy may be used to discriminate from other renal 
lesions. The immunohistochemistry of the spindled 
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could not search for the second mutation. On the 
other hand, we performed immunohistochemistry 
analyses that indicated relatively low levels of TSC2 
expression when compared to the negative control, 
corroborating that the patient has inactivating 
mutations in the TSC2 gene. In agreement, staining 
for the TSC1 protein (hamartin) disclosed relatively 
higher expression levels in the AML, and expression 
similar to tuberin (TSC2) in the kidney tissue.
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